Octreotide for bleeding as a result of hepatocellular carcinoma invasion of the gastrointestinal tract.
Tanvetyanon
Tawee
T
Tapaneeyakorn
Jiemjit
J
D001803:Blood Transfusion; D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000473:pathology; D004621:Embolization, Therapeutic / Q000379:methods; D017809:Fatal Outcome; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology*; D006509:Hepatitis B / Q000150:complications; D006801:Humans; D008099:Liver / Q000473:pathology / Q000821:virology; D008113:Liver Neoplasms / Q000150:complications* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D015282:Octreotide / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D015282:Octreotide